ArticleImmune network2018

Toll-like Receptor 1/2 Agonist Pam3CSK4 Suppresses Lipopolysaccharide-driven IgG1 Production while Enhancing IgG2a Production by B Cells.

Sang-Hoon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.